Ensign Peak Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.68M	Sell	120,840 -19,327	-14%	-$308K	﹤0.01%	742
2025 Q4	$2.28M	Sell	140,167 -9,810	-7%	-$160K	﹤0.01%	680
2025 Q3	$2.24M	Buy	+149,977	New	+$1.83M	﹤0.01%	775
2022 Q4	–	Sell	-14,700	Closed	-$105K	–	1791
2022 Q3	$105K	Hold	14,700	–	–	﹤0.01%	2081
2022 Q2	$119K	Sell	14,700 -14,562	-50%	-$128K	﹤0.01%	1928
2022 Q1	$406K	Sell	29,262 -43,832	-60%	-$689K	﹤0.01%	1640
2021 Q4	$2.05M	Sell	73,094 -9,970	-12%	-$306K	﹤0.01%	942
2021 Q3	$2.82M	Buy	83,064 +6,032	+8%	+$218K	0.01%	917
2021 Q2	$3.15M	Sell	77,032 -5,711	-7%	-$222K	0.01%	858
2021 Q1	$3.33M	Sell	82,743 -12,385	-13%	-$670K	0.01%	814
2020 Q4	$5.63M	Sell	95,128 -18,303	-16%	-$944K	0.01%	570
2020 Q3	$5.51M	Buy	113,431 +52,549	+86%	+$2.21M	0.01%	599
2020 Q2	$2.94M	Sell	60,882 -7,599	-11%	-$277K	0.01%	781
2020 Q1	$1.9M	Buy	68,481 +60,033	+711%	+$1.67M	0.01%	855
2019 Q4	$252K	Buy	+8,448	New	+$243K	﹤0.01%	1609